Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
09/15/2022 | HTG MOLECULAR DIAGNOSTICS, INC | HTGM | Grant | Stock Option (right to buy) | 8k | $0.86 | $6.9k | | 09/15/2022 |
06/17/2022 | SCYNEXIS INC | SCYX | Grant | Stock Option (Right to Buy) | 10k | $1.78 | $17.8k | | 06/17/2022 |
06/17/2022 | SCYNEXIS INC | SCYX | Grant | Common Stock | 10k | $0.00 | $0 | | 06/17/2022 |
06/16/2021 | SCYNEXIS INC | SCYX | Grant | Stock Option (Right to Buy) | 10k | $7.51 | $75.1k | | 06/16/2021 |
12/21/2020 | SCYNEXIS INC | SCYX | Purchase | Common Stock | 3.2k | $6.25 | $20k | | 12/21/2020 |
12/21/2020 | SCYNEXIS INC | SCYX | Grant | Common Stock Warrant | 1.6k | $7.33 | $11.7k | | 12/21/2020 |
12/21/2020 | SCYNEXIS INC | SCYX | Grant | Common Stock Warrant | 1.6k | $8.25 | $13.2k | | 12/21/2020 |
08/19/2020 | HTG MOLECULAR DIAGNOSTICS, INC | HTGM | Grant | Stock Option (right to buy) | 60k | $0.46 | $27.6k | | 08/19/2020 |
07/06/2020 | SCYNEXIS INC | SCYX | Grant | Stock Option (Right to Buy) | 55k | $0.73 | $40.2k | | 07/06/2020 |
07/06/2020 | SCYNEXIS INC | SCYX | Grant | Stock Option (Right to Buy) | 45k | $0.73 | $32.8k | | 07/06/2020 |
08/14/2019 | HTG MOLECULAR DIAGNOSTICS, INC | HTGM | Grant | Common Stock | 2.5k | $0.00 | $0 | | 08/14/2019 |
08/14/2019 | HTG MOLECULAR DIAGNOSTICS, INC | HTGM | Grant | Stock Option (right to buy) | 10k | $1.04 | $10.4k | | 08/14/2019 |
06/18/2019 | SCYNEXIS INC | SCYX | Grant | Stock Option (Right to Buy) | 45k | $1.29 | $58k | | 06/18/2019 |
01/02/2019 | SCYNEXIS INC | SCYX | Grant | Stock Option (right to buy) | 22.5k | $0.54 | $12.2k | | 01/02/2019 |
09/11/2018 | HTG MOLECULAR DIAGNOSTICS, INC | HTGM | Grant | Common Stock | 2.3k | $4.34 | $10k | | 09/11/2018 |
08/15/2018 | HTG MOLECULAR DIAGNOSTICS, INC | HTGM | Grant | Common Stock | 2.5k | $0.00 | $0 | | 08/15/2018 |
08/15/2018 | HTG MOLECULAR DIAGNOSTICS, INC | HTGM | Grant | Stock Option (right to buy) | 10k | $3.31 | $33.1k | | 08/15/2018 |
01/02/2018 | SCYNEXIS INC | SCYX | Grant | Stock Option (right to buy) | 20k | $2.28 | $45.6k | | 01/02/2018 |
08/15/2017 | HTG MOLECULAR DIAGNOSTICS, INC | HTGM | Grant | Stock Option (right to buy) | 6k | $2.27 | $13.6k | | 08/15/2017 |
01/03/2017 | SCYNEXIS INC | SCYX | Grant | Stock Option (right to buy) | 14.5k | $3.40 | $49.3k | | 01/03/2017 |
08/25/2016 | HTG MOLECULAR DIAGNOSTICS, INC | HTGM | Grant | Stock Option (right to buy) | 10k | $2.61 | $26.1k | | 08/25/2016 |
06/02/2016 | SCYNEXIS INC | SCYX | Grant | Stock Option (right to buy) | 8.8k | $3.98 | $35k | | 06/02/2016 |
05/25/2016 | SCYNEXIS INC | SCYX | Purchase | Common Stock | 4.2k | $3.64 | $15.4k | | 05/25/2016 |
06/19/2013 | ENDOCYTE INC | ECYT | Grant | Stock Option (right to buy) | 14k | $12.94 | $181.2k | | 06/19/2013 |
05/16/2012 | ENDOCYTE INC | ECYT | Sale | Common Stock | 25.8k | $6.65 | $171.3k | By Burrill Life Sciences Capital Fund, L.P. | 05/16/2012 |
05/16/2012 | ENDOCYTE INC | ECYT | Sale | Common Stock | 2.1k | $6.65 | $14.2k | By Burrill Indiana Life Sciences Capital Fund, L.P. | 05/16/2012 |
05/26/2011 | ENDOCYTE INC | ECYT | Grant | Stock Option (right to buy) | 10k | $11.80 | $118k | | 05/26/2011 |
02/09/2011 | ENDOCYTE INC | ECYT | Grant | Stock Option (right to buy) | 15.7k | $7.23 | $113.6k | | 02/09/2011 |
02/09/2011 | ENDOCYTE INC | ECYT | Conversion | Series C-3 Convertible Preferred Stock | 427.6k | $0.00 | $0 | By Burrill Life Sciences Capital Fund, L.P. | 02/09/2011 |
02/09/2011 | ENDOCYTE INC | ECYT | Conversion | Series C-2 Convertible Preferred Stock | 341.2k | $0.00 | $0 | By Burrill Life Sciences Capital Fund, L.P. | 02/09/2011 |
02/09/2011 | ENDOCYTE INC | ECYT | Conversion | Common Stock | 63.9k | $0.00 | $0 | By Burrill Indiana Life Sciences Capital Fund, L.P. | 02/09/2011 |
02/09/2011 | ENDOCYTE INC | ECYT | Conversion | Common Stock | 768.8k | $0.00 | $0 | By Burrill Life Sciences Capital Fund, L.P. | 02/09/2011 |
02/09/2011 | ENDOCYTE INC | ECYT | Conversion | Series C-3 Convertible Preferred Stock | 35.6k | $0.00 | $0 | By Burrill Indiana Life Sciences Capital Fund, L.P. | 02/09/2011 |
02/09/2011 | ENDOCYTE INC | ECYT | Conversion | Series C-2 Convertible Preferred Stock | 28.4k | $0.00 | $0 | By Burrill Indiana Life Sciences Capital Fund, L.P. | 02/09/2011 |
02/04/2011 | ENDOCYTE INC | ECYT | Grant | Common Stock | 461.6k | $6.00 | $2.8M | By Burrill Life Sciences Capital Fund, L.P. | 02/04/2011 |
|